Increased susceptibility to sporadic Parkinson's disease by a certain combined α-synuclein/apolipoprotein E genotype

Annals of Neurology

Volumn 45, Issue 5, 1999, Pages 611-617

  Krüger, Rejko ^a   Vieira Saecker, Ana Maria Menezes ^a   Kuhn, Wilfried ^a   Berg, Daniela ^b   Müller, Thomas ^a   Kühnl, Natalia ^c   Fuchs, Gerd A ^c   Storch, Alexander ^d   Hungs, Marcel ^e   Woitalla, Dirk ^a   Przuntek, Horst ^a   Epplen, Jörg T ^a   Schöls, Ludger ^a   Riess, Olaf ^a,f  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Parkinson Klinik Wolfach   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SUBSTANTIA NIGRA;

AGED; ALLELES; ALPHA-SYNUCLEIN; APOLIPOPROTEINS E; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; NERVE TISSUE PROTEINS; PARKINSON DISEASE; SYNUCLEINS; TANDEM REPEAT SEQUENCES; TIME FACTORS;

EID: 0342950666     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X     Document Type: Article

References (38)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55: 181-184
2. Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson's disease to chromosome 4q12-q23. Science 1997;274:1197-1199
3. Polymeropoulos MH, Laavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
4. Krüger R, Kuhn W, Müller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998;18:106-108
5. Gasser T, Muller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-265
6. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608
7. Barbeau A, Roy M, Bernier G, et al. Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci 1987;14:36-41
8. Spillantini MG, Schmidt ML, Lee VM, et al. α-Synuclein in Lewy bodies. Nature 1997;388:839-840
9. Hulette C, Mirra S, Wilkinson W, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's disease features in Alzheimer's disease. Neurology 1995;45:1991-1995
10. Hofman A, Schulte W, Tanja TA, et al. History of dementia and Parkinson's disease in 1st degree relatives of patients with Alzheimer's disease. Neurology 1989;39:1589-1592
11. Welch WJ, Gambetti P. Chaperoning brain diseases. Nature 1998;392:23-24
12. Schellenberg GD. Genetic dissection of Alzheimer's disease, a heterogenous disorder. Proc Natl Acad Sci USA 1995;92:8552-8559
13. Koller WC, Glatt SL, Hubble JP, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 1995;37:242-245
14. Inzelberg R, Paleacu D, Chapman N, Korczyn AD. Apolipoprotein E and Parkinson's disease. Ann Neurol 1998;44:294 (Letter)
15. Zareparsi S, Kaye J, Camicioli R, et al. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes. Ann Neurol 1997;42:655-658
16. The French Parkinson's Disease Genetics Study Group. Apolipoprotein E genotype in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:394-395
17. De la Fuente-Fernandez R, Sellers A, Beyer K, Lao JI. Apolipoprotein E genotypes and age at onset of Parkinson's disease. Ann Neurol 1998;44:294-295
18. Egensperger R, Bancher C, Kosel S, et al. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions. Biochem Biophys Res Commun 1996;224:484-486
19. Epplen C, Jackel S, Santos EJ, et al. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann Neurol 1997;41:341-352
20. Lambert JC, Pasquier F, Cottel D, et al. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998;7:533-540
21. Svejgard A, Ryder LP. HLA and disease 1982: a survey. Immunol Rev 1983;70:193-218
22. Svejgard A, Rydet LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43:18-27
23. Hamada H, Seidman M, Howard BH, Gorman CM. Enhanced gene expression by poly(dT-dG)•poly(dC-dA) sequence. Mol Cell Biol 1984;4:2622-2630
24. Berg DT, Walls JD, Reifel-Miller AE, Grinnell BW. E1A-induced enhancer activity of the poly(dG-dT)•poly(dA-dC) element (GT element) and interactions with a GT-specific nuclear factor. Mol Cell Biol 1989;9:5248-5253
25. Andrew S, Theilmann J, Hedrick A, et al. Nonrandom association between Huntington disease and two loci separated by about 3 Mb on 4p16.3. Genomics 1992;13:301-311
26. Utermann G, Langenback U, Beisiegel U, Weber W. Genetics of apolipoprotein E system in man. Am J Hum Genet 1980; 32:339-347
27. Lambert JC, Perez-Tur J, Dupire MJ, et al. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum Mol Genet 1997;12:2151-2154
28. Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998;21:249-254
29. Riess O, Jakes R, Krüger R. Genetic dissection of familial Parkinson's disease. Mol Med Today 1998;4:438-444
30. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368-372
31. Hotamisligil GS, Girmen S, Fink S, et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinsons's disease. Mov Disord 1994;9:305-310
32. Costa P, Checkoway H, Levy D, et al. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 1997;74:154-156
33. Bandmann O, Vaughan J, Holmans P, et al. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1997;350:1136-1139
34. 1-antichymotrypsin polymorphism. Brain Res 1997;759:153-155
35. Smith CAD, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377
36. Wilhelmsen K, Mirel D, Marder K, et al. Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13. Ann Neurol 1997;41:813-817
37. Planté-Bordeneuve V, Taussig D, Thomas F, et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 1997;48:1589-1593
38. Kobayashi T, Matsumine H, Matuda S, Mizuno Y. Association between the gene encoding the E2 subunit of the α-ketoglutarate dehydrogenase complex and Parkinson's disease. Ann Neurol 1998;43:120-123